Randomized, Double-Blind Study of SR142801 (Osanetant). A Novel Neurokinin-3 (NK3) Receptor Antagonist in Panic Disorder with Pre- and Posttreatment Cholecystokinin Tetrapeptide (CCK-4) Challenges - Kronenberg, G; Berger, P; Tauber, R F; Bandelow, B; Henkel, V; Heuser, I (Pharmacopsychiatry, 2005)